Insights: Partisan control, Warren Buffett + JDRF Ride to Defeat Diabetes
Good reads:
Best quote of the week:
“A politician needs the ability to foretell what is going to happen tomorrow, next week, next month, and next year. And to have the ability afterwards to explain why it didn't happen.” – Winston Churchill
Best visuals of the week:
Did you partake in many political debates around the Thanksgiving dinner table last weekend? Well, if you’re looking for some more fodder, you can debate on which party has historically been better for stocks.
Below is a great chart from Fidelity Investments that answers that question. If you look solely at the data, Democratic presidents tend to be the winners. However, if you drill a little further down, it’s not quite as clearcut.
As Fidelity noted in their research report, “… the party that’s been better for the stock market over the long term has differed based on the timeframe studied and whether annualized results were calculated using a mean or a median, for instance. There hasn't been a clear edge based on the party in control of the White House. Other political factors—such as whether Congress is divided—have had more influence on market performance over many years. […] Bottom line: Stock returns have been driven far more by the strength of the U.S. business cycle, consumer spending, and corporate profit growth than the party in the administrative office.
And on that note, wondering what has historically been the best mix? Markets appear to favour a split outcome:
Best soundbite of the week:
Every now and then some media pundit will come along and harp on Warren Buffett. That’s because Buffett will occasionally have periods of time where he underperforms. Pundits will jump on that and make ridiculous statements like “he’s lost his touch.” However, as you’ll see via the performance of his Berkshire Hathaway, all it takes is a bit of time to realize how truly remarkable the man is:
“Berkshire Hathaway’s stock price (the current Class A shares) and the S&P 500 index both stood at 100 in May 1977. The index is up nearly 60-fold since then, but Berkshire shares are up to $680,000, or more than 6,000-fold.” – Barron’s article
6,000 fold…that’s not a typo!
You’re Invited: Quarterly Market Update – U.S. Election Edition
Join Raymond James’ Neil Linsdell, Head of Investment Strategy, Ed Mills, Managing Director, Washington Policy, Eugenio Aleman, Chief Economist, and Tavis McCourt, Institutional Equity Strategist, for a quarterly update on financial markets and insights into what to expect in the market with the upcoming U.S. election.
Date: October 23, 2024
Time: 10am-11am PT/11am-12pm MT/1-2pm ET
Contact me for a registration link: kim.inglis@raymondjames.ca
Recommended by LinkedIn
JDRF Ride to Defeat Diabetes
My amazing and talented assistant Saundra is the team captain for our Kelowna branch’s efforts in fundraising for the JDRF Ride to Defeat Diabetes. This week we had our team event, where we all unleashed our inner cyclist in support of the JDRF.
If you’d like to learn more about it or support Saundra’s fundraising, here is the link.
Beyond the markets:
In honour of Saundra’s fundraising efforts, I thought I’d share some facts about Type 1 diabetes (T1D):
· Type 1 diabetes (T1D) is a chronic autoimmune condition in which insulin-producing beta cells in the pancreas are mistakenly destroyed by the body’s immune system.
· Insulin is the hormone made by the pancreas that allows the body to use sugar (glucose) from carbohydrates in food consumed for energy.
· To survive, people with T1D must monitor their blood sugar throughout the day and take insulin via multiple daily injections (MDI) or via an insulin pump.
· Insulin is a treatment for T1D, but there is no cure.
· T1D can occur in people of any age, and its causes are not fully known.
· Genetics plays a role, as the condition tends to run in families, but 85-90% of people who are diagnosed have no family history.
· What we do know is that diet or lifestyle don’t cause T1D, it isn’t contagious or something you can outgrow, and it’s not currently preventable or curable.
Source: JDRF
Thanks for reading, and I wish everyone a wonderful weekend!
Cheers,
Kim
Kim Inglis, BCom, CIM, PFP, FCSI, RIAC
Senior Portfolio Manager
T: 416.777.6417 (Toronto)
T: 604.654.1160 (Vancouver)
T: 250.979.1803 (Kelowna)
TF: 1.877.363.1024
The opinions expressed in this newsletter are those of the Financial Advisor Kim Inglis, BCom, CIM, PFP, FCSI, CAFA and not necessarily those of Raymond James Ltd. (“RJL”) or Raymond James (USA) Ltd. (“RJLU”). Statistics, factual data and other information presented are from sources, believed to be reliable but accuracy cannot be guaranteed. It is furnished on the basis and understanding that Raymond James Ltd. and Raymond James (USA) Ltd. is to be under no liability whatsoever in respect thereof. It is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Raymond James Ltd. and Raymond James (USA) Ltd. financial advisors may only transact business in provinces and/or states where they are registered. Follow-up and individualized responses involving either the effecting of or attempting to effect transactions in securities, or the rendering of personalized investment advice for compensation, will not be made to persons in provinces or states where the financial advisor is not registered. Raymond James Ltd. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund. Raymond James (USA) Ltd. is a member of FINRA/SIPC. Raymond James (USA) Ltd. (RJLU) and advisors may only conduct business with residents of the states and/or jurisdictions for which they are properly registered. This provides links to other Internet sites for the convenience of users. Raymond James Ltd. is not responsible for the availability or content of these external sites, nor does Raymond James Ltd endorse, warrant or guarantee the products, services or information described or offered at these other Internet sites. Users cannot assume that the external sites will abide by the same privacy policy which Raymond James Ltd adheres to.